Insights
-
Featured
Ten years of the Damages Directive: Three ways to better use economic analysis in court
-
Featured
Is the threat of retaliation by customers an economically sound defence to input foreclosure?
-
Featured
Bad Blood? Appetite for State aid concepts in Southeast Asia since Taylor Swift’s exclusivity deal
-
Featured
The Landscape under China’s New Anti-Monopoly Law: An Economic Perspective
Showing 1–17 of 17 results
-
-
-
News • 01 May 2024
Compass Lexecon Expands EMEA Presence with New Lisbon Office
-
Article • 19 Jan 2024
Use of Economists in Competition Law Investigations
-
-
News • 05 Jun 2023
Top Antitrust Expert Dr. Loren Smith Rejoins Compass Lexecon
-
News • 01 Jun 2023
Leading Antitrust Expert Dr. Lona Fowdur Joins Compass Lexecon
-
Article • 10 Mar 2023
Evolving market boundaries and competition policy
-
-
Article • 01 Nov 2022
The Guide to Life Sciences: An Economist's Perspective
-
Article • 15 Jun 2022
Defining relevant markets in the pharmaceutical industry
-
The Analysis • 22 Mar 2022
Assessing vertical integration between hospitals and insurers
-
-
Article • 05 Dec 2011
The Economic Benefits of Pharmacy Benefit Managers - J. Orszag & K. Green
-
-
Article • 24 Jun 2009
A Preliminary Economic Analysis of FTC Chairman Leibowitz’s June 23rd Speech
-
Article • 17 Dec 2008
Orszag, Dickey and Tyson Paper Evaluating Competitive Effects of Patent Settlements
Follow us on LinkedIn for all the latest conversations
“We are delighted to share that 11 Compass Lexecon articles have been nominated in the Concurrences 2024 Antitrust Writing Awards...”
34